GGentell makes and distributes a broad range of wound care products for settings like hospitals, nursing homes, and hospices. Its lineup includes traditional and advanced dressings (gel, collagen, foams, hydrocolloids), skin protection products (ointments, barrier creams, cleansers, sanitizers), and related supplies such as tapes and fixation devices, produced in the United States, Canada, and China. Wound care items are designed to manage moisture, protect the wound, support healing, and prevent infection, using both traditional materials and advanced dressings. Gentell stands apart by combining a wide product portfolio with vertical integration and a nationwide team of clinical specialists who guide treatment and educate users to improve patient outcomes.
Work here?Claim your company
Industries
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
Bristol, VA
Founded
1994
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Harpeth Capital advises First Honey on sale to Gentell. News and Articles Transactions July 21, 2026 Harpeth Capital is pleased to announce that it served as exclusive financial advisor to Nashville-based First Honey, LLC ("First Honey" or the "Company") in connection with its sale to Gentell, a leading manufacturer of advanced wound care products. Co-founded by Jonathan "Jono" Scarlett and Sarah Scarlett, First Honey is a consumer health and wellness company built around medical-grade Manuka honey. The Company's product portfolio includes ointments, creams, first aid, and skin care products made with high-potency Manuka honey. First Honey products are sold in more than 9,000 retail locations across the United States, including Whole Foods, Sprouts Farmers Market, and CVS, as well as through leading online retailers, including Amazon, Walmart, and firsthoney.com. "Building First Honey has been the privilege of a lifetime, and finding the right home for the brand mattered deeply to Sarah and me," said Jono Scarlett, Co-Founder of First Honey. "Chuck and the Harpeth team were trusted advisors from the initial founding of the business, and their counsel was invaluable. Gentell shares our belief in the power of Manuka honey, and I'm confident the brand will thrive on their platform." "We are pleased to have advised Jono and Sarah on this transaction," said Chuck Byrge, CEO of Harpeth Capital. "Jono and Sarah built First Honey from an idea into a nationally distributed brand with real staying power on the shelf. Gentell is a natural fit, combining First Honey's consumer reach with Gentell's clinical wound care expertise, and we look forward to watching the brand's next chapter." Smith Hulsey served as legal advisor to First Honey.
Gentell, the largest vertically integrated wound care company, has acquired Innovative Supply Group (ISG), a leading Medicare Part B supplier of medical tube devices to North American nursing homes. Financial terms were not disclosed. ISG will operate as Gentell Nutritional Services, with Michael Lebovics, formerly ISG's president, leading the division. Gentell currently serves over 30% of the estimated 15,000 US nursing homes with wound care supplies. The acquisition is expected to expand its market share by approximately 12%. This marks Gentell's third acquisition in 12 months, following purchases of New Zealand-based Manukamed and Paraguay-Brazil manufacturer Casex. The company now operates manufacturing facilities across five continents and has increasingly focused on linking nutrition to wound care for improved healing outcomes.
Gentell, led by CEO David Navazio, has acquired New Zealand-based ManukaMed, a manufacturer of honey-based wound dressings. This acquisition allows Gentell to control the only honey-based wound care product reimbursable by Medicare and other U.S. insurance organizations. ManukaMed's patented medical-grade honey blend is proven effective for healing venous ulcers, pressure ulcers, and chronic wounds.
Gentell, the world's largest vertically integrated wound care company, has expanded its global presence by acquiring Casex, a leading Latin American manufacturer of ostomy and wound care products. Announced by Gentell's President and CEO, David Navazio, on June 5, 2025, the acquisition will see Casex rebranded under the Gentell name, enhancing Gentell's distribution capabilities in Latin America.
Gentell unveils ai-powered Wound Care management system.
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
Industries
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
Bristol, VA
Founded
1994
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs